Ze‐Ya Pan

2.8k citations

55 papers · 2.1k · h-index 22

Impact in

Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research

Papers in

Hepatology 26
- Hepatocellular Carcinoma Treatment and Prognosis 25
Molecular Biology 13
- Ubiquitin and proteasome pathways 3
- RNA Research and Splicing 2

Co-authors: Weiping Zhou (35 shared papers)Wan Yee Lau (20 shared papers)Yuan Yang (22 shared papers)Mengchao Wu (15 shared papers)Eric C. H. Lai (7 shared papers)Gang Huang (16 shared papers)Siyuan Fu (19 shared papers)Weiping Zhou (8 shared papers)
Journals: Annals of Surgery (5 papers)Oncotarget (3 papers)Journal of Gastrointestinal Surgery (3 papers)Hepatology (2 papers)Molecular Oncology (2 papers)
Partner nations: China Hong Kong United States

In The Last Decade

Ze‐Ya Pan

53 papers receiving 2.0k citations

Peers

Countries citing papers authored by Ze‐Ya Pan

Since Specialization

Citations

This map shows the geographic impact of Ze‐Ya Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ze‐Ya Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ze‐Ya Pan more than expected).

Fields of papers citing papers by Ze‐Ya Pan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ze‐Ya Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ze‐Ya Pan. The network helps show where Ze‐Ya Pan may publish in the future.

Co-authors

The 25 scholars most cited alongside Ze‐Ya Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ze‐Ya Pan Line = papers co-authored together Ze‐Ya Pan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: A RCT Journal of Hepatology ·Lei Yin, Hui Li, Aijun Li, Wan Yee Lau, Ze‐Ya Pan, Eric C. H. Lai, Mengchao Wu, Weiping Zhou	2014	239
2	microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity British Journal of Cancer ·J Zhang, Yuan Yang, Tian Yang, Yige Liu, A. Li, Shimin Fu, M. Wu, Ze‐Ya Pan, Weiping Zhou	2010	226
3	Human CD14+CTLA-4+ Regulatory Dendritic Cells Suppress T-Cell Response by Cytotoxic T-Lymphocyte Antigen-4-Dependent IL-10 and Indoleamine-2,3-Dioxygenase Production in Hepatocellular Carcinoma Hepatology ·Yanmei Han, Zhubo Chen, Yuan Yang, Zhengping Jiang, Yan Gu, Yanfang Liu, Chuan Lin, Ze‐Ya Pan, Yizhi Yu, Minghong Jiang, Weiping Zhou, Xuetao Cao	2013	193
4	A Prospective, Randomized, Controlled Trial of Preoperative Transarterial Chemoembolization for Resectable Large Hepatocellular Carcinoma Annals of Surgery ·Weiping Zhou, Eric C. H. Lai, Aijun Li, Siyuan Fu, Jianping Zhou, Ze‐Ya Pan, Wan Yee Lau, Meng-Chao Wu	2009	162
5	Antiviral Therapy Improves Postoperative Survival in Patients With Hepatocellular Carcinoma Annals of Surgery ·Gang Huang, Wan Yee Lau, Zhenguang Wang, Ze‐Ya Pan, Shengxian Yuan, Feng Shen, Weiping Zhou, Meng-Chao Wu	2014	156
6	Antiviral Therapy Reduces Hepatocellular Carcinoma Recurrence in Patients With Low HBV-DNA Levels Annals of Surgery ·Gang Huang, Pengpeng Li, Wan Yee Lau, Ze‐Ya Pan, Linghao Zhao, Zhenguang Wang, Meng‐chao Wang, Weiping Zhou	2018	99
7	Posthepatectomy HBV Reactivation in Hepatitis B–Related Hepatocellular Carcinoma Influences Postoperative Survival in Patients With Preoperative Low HBV-DNA Levels Annals of Surgery ·Gang Huang, Eric C. H. Lai, Wan Yee Lau, Weiping Zhou, Feng Shen, Ze‐Ya Pan, Siyuan Fu, Mengchao Wu	2012	97
8	Roles of Chemokine Receptor 4 (CXCR4) and Chemokine Ligand 12 (CXCL12) in Metastasis of Hepatocellular Carcinoma Cells Cellular and Molecular Immunology ·Hui Liu, Ze‐Ya Pan, Aijun Li, Siyuan Fu, Lei Yin, Hangyong Sun, Mengchao Wu, Weiping Zhou	2008	76
9	Double‐negative feedback loop between MicroRNA‐422a and forkhead box (FOX)G1/Q1/E1 regulates hepatocellular carcinoma tumor growth and metastasis Hepatology ·Jin Zhang, Yun Yang, Tian Yang, Shengxian Yuan, Ruoyu Wang, Ze‐Ya Pan, Yuan Yang, Gang Huang, Fangming Gu, Bei‐Ge Jiang, Chuan Lin, Weiping Zhou	2014	66
10	Inflammatory Myofibroblastic Tumor of the Liver: A Cohort Study World Journal of Surgery ·Liang Tang, Eric C. H. Lai, Wen‐Ming Cong, Aijun Li, Siyuan Fu, Ze‐Ya Pan, Weiping Zhou, Wan Yee Lau, Mengchao Wu	2009	52
11	Hepatitis B virus X protein promotes the stem-like properties of OV6+ cancer cells in hepatocellular carcinoma Cell Death and Disease ·Chao Wang, Ming-Da Wang, (unknown), Hai Huang, Wei Dong, Weiwei Zhang, Pengpeng Li, Chuan Lin, Ze‐Ya Pan, Mengchao Wu, Weiping Zhou	2017	50
12	Prediction of Hepatocellular Carcinoma Recurrence in Patients With Low Hepatitis B Virus DNA Levels and High Preoperative Hepatitis B Surface Antigen Levels JAMA Surgery ·Gang Huang, Wan Yee Lau, Weiping Zhou, Feng Shen, Ze‐Ya Pan, Shengxian Yuan, Mengchao Wu	2014	47
13	Selective hepatic vascular exclusion and Pringle maneuver: A comparative study in liver resection European Journal of Surgical Oncology ·Weiping Zhou, A. Li, Ze‐Ya Pan, Shimin Fu, Yuan Yang, Liang Tang, Zongliu Hou, M. Wu	2007	38
14	The histone acetyltransferase hMOF suppresses hepatocellular carcinoma growth Biochemical and Biophysical Research Communications ·Jin Zhang, Hui Liu, Hào Pān, Yuan Yang, Gang Huang, Yun Yang, Weiping Zhou, Ze‐Ya Pan	2014	35
15	Early Viral Suppression Predicts Good Postoperative Survivals in Patients with Hepatocellular Carcinoma with a High Baseline HBV-DNA Load Annals of Surgical Oncology ·Gang Huang, Yuan Yang, Feng Shen, Ze‐Ya Pan, Siyuan Fu, Wan Yee Lau, Weiping Zhou, Mengchao Wu	2012	32
16	Human hepatocellular carcinoma-infiltrating CD4+CD69+Foxp3− regulatory T cell suppresses T cell response via membrane-bound TGF-β1 Journal of Molecular Medicine ·Yanmei Han, Yuan Yang, Zhubo Chen, Zhengping Jiang, Yan Gu, Yanfang Liu, Sheng Xu, Chuan Lin, Ze‐Ya Pan, Weiping Zhou, Xuetao Cao	2014	31
17	Tumor SOCS3 methylation status predicts the treatment response to TACE and prognosis in HCC patients Oncotarget ·Bei‐Ge Jiang, Neng Wang, Jian Huang, Yuan Yang, Liangliang Sun, Ze‐Ya Pan, Weiping Zhou	2017	29
18	IL‐17A promotes the invasion–metastasis cascade via the AKT pathway in hepatocellular carcinoma Molecular Oncology ·Qingguo Xu, Jian Yu, Xinggang Guo, Guojun Hou, Shengxian Yuan, Yuan Yang, Yun Yang, Hui Liu, Ze‐Ya Pan, Fu Yang, Fangming Gu, Weiping Zhou	2018	27
19	Nomograms to predict the long‐time prognosis in patients with alpha‐fetoprotein negative hepatocellular carcinoma following radical resection Cancer Medicine ·Jian Huang, Fuchen Liu, Li Li, Weiping Zhou, Bei‐Ge Jiang, Ze‐Ya Pan	2020	26
20	A Prospective Randomized Controlled Trial to Compare Pringle Manoeuvre with Hemi-hepatic Vascular Inflow Occlusion in Liver Resection for Hepatocellular Carcinoma with Cirrhosis Journal of Gastrointestinal Surgery ·Jun-sheng Ni, Wan Yee Lau, Yuan Yang, Ze‐Ya Pan, Zhenguang Wang, Hui Liu, Mengchao Wu, Weiping Zhou	2013	24

About Ze‐Ya Pan

Ze‐Ya Pan is a scholar working on Hepatology, Molecular Biology, Oncology, Cancer Research and Surgery, having authored 55 papers that have together received 2.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (25 papers), Ubiquitin and proteasome pathways (3 papers), T-cell and B-cell Immunology (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Cancer, Lipids, and Metabolism (2 papers), RNA Research and Splicing (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Hippo pathway signaling and YAP/TAZ (2 papers). The work is most often cited by research in Hepatology (965 citations), Cancer Research (341 citations), Epidemiology (448 citations), Oncology (360 citations) and Immunology (216 citations). Ze‐Ya Pan has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Weiping Zhou, Wan Yee Lau, Yuan Yang, Mengchao Wu, Eric C. H. Lai, Gang Huang, Siyuan Fu, Weiping Zhou, Aijun Li and Shengxian Yuan. Their work appears in journals such as Annals of Surgery, Oncotarget, Journal of Gastrointestinal Surgery, Hepatology and Molecular Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Ze‐Ya Pan

Impact in

Papers in i

In The Last Decade

Ze‐Ya Pan

Peers

Countries citing papers authored by Ze‐Ya Pan

Fields of papers citing papers by Ze‐Ya Pan

All Works

About Ze‐Ya Pan

Explore authors with similar magnitude of impact

Papers in